Beximco Pharmaceuticals Ltd 2014 AR2
The report highlights Beximco Pharmaceuticals Limited's performance for the fiscal year 2014, during which the company crossed the BDT 10 billion mark in domestic sales for the first time. Key achievements include receiving GMP accreditation from Health Canada and the Taiwan Food & Drug Administration, and successfully completing a US FDA inspection in early 2015. The company expanded its global footprint by entering new markets in Romania and Uganda, and launching 28 new products domestically. Beximco also continued its commitment to corporate social responsibility through various healthcare, education, and environmental initiatives.
Company: Beximco Pharmaceuticals Ltd
Sector: Manufacturing
Country: Bangladesh
Year: 2014
Type: AR2
Pages: 91
Back to company
Beximco Pharmaceuticals Ltd
Annual Report
The report highlights Beximco Pharmaceuticals Limited's performance for the fiscal year 2014, during which the company crossed the BDT 10 billion mark in domestic sales for the first time. Key achievements include receiving GMP accreditation from Health Canada and the Taiwan Food & Drug Administration, and successfully completing a US FDA inspection in early 2015. The company expanded its global footprint by entering new markets in Romania and Uganda, and launching 28 new products domestically. Beximco also continued its commitment to corporate social responsibility through various healthcare, education, and environmental initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees